Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Antibody-Drug Conjugates
February 11, 2025
News
Precision Cancer Therapy Driving Investment and Innovation Antibody-drug conjugates (ADCs) are rapidly emerging as a transformative force in precision medicine, revolutionizing cancer treatment by combining the targeting precision of monoclonal…
READ MORE
KYBORA is attending Bio Partnering at JPM
December 8, 2020
News
KYBORA is attending Bio Partnering at JPM. We look forward to connecting with you there and show you how to…
READ MORE
KYBORA announces that Bayer Healthcare Pharmaceuticals has sold a PRV to argenx
November 23, 2020
Mergers and Acquisitions, News
KYBORA is pleased to announce that its client Bayer Healthcare Pharmaceuticals has sold a Priority Review Voucher (PRV) to argenx.
READ MORE
Russian Federation Pharma – March 2020 update
June 8, 2020
News
KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular…
READ MORE
KYBORA Sponsors the Bio Latin America Conference Again
May 30, 2020
News
KYBORA is happy to announce that it will sponsor the Bio Latin America Conference again this year. Taking place in…
READ MORE
Is China High Enough on Your Priority List?
May 28, 2020
News
“If you are a U.S. company that does not yet have a China strategy…you need to get moving or risk…
READ MORE
KYBORA successfully helps Stada license Xlucane to Bausch Health
May 6, 2020
News
KYBORA is pleased to announce that it has successfully helped its client STADA Arzneimittel AG license Xlucane – a Ranibizumab…
READ MORE
KYBORA Welcomes Anton Leshchenko to the Team
April 13, 2020
News
KYBORA is pleased to announce that Anton Leshchenko has joined its team as Managing Director, responsible for expanding KYBORA’s operations…
READ MORE
KYBORA Welcomes Rainer Wulf to the Team
April 13, 2020
News
KYBORA is pleased to announce that Rainer Wulf has joined Kybora as a new member of the advisory board. Rainer…
READ MORE
KYBORA Successfully Helps STADA License Xlucane to Bausch Health
February 26, 2020
News
READ MORE
«
‹
4
5
6
TYPE & ENTER:
Close
